Clinical Trial Update: Soluble Epoxide Hydrolase Inhibition and Insulin Resistance [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on soluble epoxide hydrolase inhibition for insulin resistance with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Endocrine System Diseases
• Glucose Metabolism Disorders
• Obesity
• Pre-diabetes

Drugs mentioned

• Soluble epoxide hydrolase inhibitor

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Diabetes Mellitus, Endocrine System Diseases | Phase 2 | Status: COMPLETED | Results posted: 2023-03-23